Sensex ends below 28,700; defensive shares drag

The 30-share Sensex shed 134 points to close at 28,666 and the 50-share Nifty dropped 44 points to end at 8,707

Indrani Mazumdar Mumbai
Last Updated : Apr 16 2015 | 4:32 PM IST
Benchmark indices ended lower for the second straight session with IT and healthcare stocks contributing the most to the decline on the back of lacklustre US economic data for the month of March. Further, expectations of sluggish revenue growth during the fourth quarter from TCS also weighed on sentiment.

The 30-share Sensex shed 134 points to close at 28,666 and the 50-share Nifty dropped 44 points to end at 8,707.

RUPEE

The rupee slipped by 2 paise at 62.38 against the US dollar in the late noon trade following bouts of demand for dollar from importers amid volatile equities.

KEY STOCKS

On the sectoral front, BSE Healthcare, Realty, IT, Capital Goods ended down up to 2%. However, BSE Oil & Gas index emerged as the only gainer and was up nearly 1%.

ONGC emerged as the top gainer and surged over 3%. According to media reports, government has decided to exempt ONGC and Oil India from sharing subsidy in the fourth quarter of fiscal 2015. GAIL was up 0.5%.

RIL gained 0.7% as analysts expect the company to post a record fourth quarter net profit as benefitting from refining margins, which will be partially offset by lower petrochemical margins. RIL will announce its January-March 2015 results on Friday.

Auto stocks which gained in the morning deals after public sector oil marketing companies announced a reduction in retail selling price of petrol and diesel ended the session in the negative territory on account of profit booking. Bajaj Auto, Maruti Suzuki, Tata Motors declined up to 4%.

Meanwhile, Hero Motocorp emerged as the top loser after US-based Erik Buell Racing (EBR), in which Hero MotoCorp holds 49% stake, announced a closure of operations. The stock ended 3.8% lower.

Export oriented stocks such as healthcare and IT declined on the back of lacklustre US economic data for the month of March.

Lupin lost over 2.5% after its rival Aurobindo Pharma got a nod from US Food and Drug Administration (USFDA) to make and sell its generic version of oral suspension of antibiotic Cefixime.

Among its peers, Cipla, Sun Pharma and Dr Reddy's Labs lost between 2-3%.

The IT pack faced further selling pressure as analysts expect TCS to post a mute quarterly result. The result will be announced post the market hours today. Infosys, Wipro, TCS ended lower up to 2%.

IndusInd Bank posted a 25% rise in net profit for the fourth quarter ended March 31, 2015. The bank posted profit after tax of Rs 495.27 crore for Q4 FY15 compared to Rs 396.05 crore in Q4 of FY14. The stock ended the session with marginal losses.

Tata Steel dropped nearly 0.5% after the company said that its crude steel production fell 1.45% to 2.44 million tonnes in Q4 March 2015 over Q4 March 2014. Its peer Sesa Sterlite is trading lower by 3%.

FMCG majors ITC and HUL lost up to 1.7% on Nomura report stating that the possibility that the El Nino condition is developing this year and this could possibly push food inflation temporarily higher.

After gaining in the past sessions, both the BSE Midcap and Smallcap indices, down 0.7% and 0.9% each succumbed to profit booking at higher levels. Market breadth on the BSE is weak with 1,711 declines against 1,089 advances.

Shares of Gammon India surged 12% on the Bombay Stock Exchange after the infrastructure company annnounced that it has secured two new projects worth Rs 840.45 crore.

Shares of state-owned oil marketing companies (OMCs) – Indian Oil Corporation, HPCL and BPCL ended lower up to 2.5% on the BSE after the companies announced a reduction in retail selling price of petrol and diesel after trading hours yesterday, 15 April 2015.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 16 2015 | 3:53 PM IST

Next Story